We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+2.48%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.7B
AUM Growth
-$392M
(-1.7%)
Cap. Flow
-$683M
Cap. Flow
% of AUM
-3.01%
Top 10 Holdings %
Top 10 Hldgs %
13.52%
Holding
1,954
New
218
Increased
445
Reduced
978
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Weyerhaeuser
WY
|
+$41.7M |
| 3 |
Mondelez International
MDLZ
|
+$34M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$33.6M |
| 5 |
Lazard
LAZ
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$96.8M |
| 2 |
HCA Healthcare
HCA
|
+$70.3M |
| 3 |
HP
HPQ
|
+$51.1M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$49.2M |
| 5 |
T. Rowe Price
TROW
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.91% |
| 2 | Technology | 14.75% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OUTR
826
DELISTED
OUTERWALL INC
OUTR
| $932K | ﹤0.01% |
14,100
-400
| -3% | -$26.8K |
|
|
SPTN
827
DELISTED
SpartanNash
SPTN
| $927K | ﹤0.01% |
+29,400
| New | +$793K |
|
|
OMG
828
DELISTED
OM GROUP INC.
OMG
| $927K | ﹤0.01% |
30,900
-800
| -3% | -$23.3K |
|
|
STMP
829
DELISTED
Stamps.com, Inc.
STMP
| $921K | ﹤0.01% |
+13,700
| New | +$729K |
|
830
MiMedx Group
MDXG
$626M
| $919K | ﹤0.01% |
88,400
+64,837
| +275% | +$607K |
|
831
Helios Technologies
HLIO
$2.64B
| $918K | ﹤0.01% |
22,200
-900
| -4% | -$34.8K |
|
|
KEF
832
DELISTED
Korea Equity Fund
KEF
| $918K | ﹤0.01% |
120,000
| – | – |
|
833
Zumiez
ZUMZ
$320M
| $913K | ﹤0.01% |
22,700
-600
| -3% | -$23.3K |
|
834
Cigna
CI
$76.6B
| $912K | ﹤0.01% |
+7,051
| New | +$819K |
|
|
AFFX
835
DELISTED
Affymetrix Inc
AFFX
| $910K | ﹤0.01% |
72,500
-14,500
| -17% | -$168K |
|
836
First Commonwealth Financial
FCF
$2.12B
| $908K | ﹤0.01% |
100,900
+1,100
| +1% | +$9.46K |
|
|
TPC
837
Tutor Perini Cor
TPC
$4.57B
| $908K | ﹤0.01% |
38,900
-1,900
| -5% | -$44.6K |
|
838
Standard Motor Products
SMP
$861M
| $904K | ﹤0.01% |
21,400
-1,300
| -6% | -$50.7K |
|
839
Universal Insurance Holdings
UVE
$1.16B
| $903K | ﹤0.01% |
35,300
-5,600
| -14% | -$132K |
|
840
Alaunos Therapeutics
TCRT
$4.74M
| $902K | ﹤0.01% |
+559
| New | +$828K |
|
|
EBIX
841
DELISTED
Ebix Inc
EBIX
| $902K | ﹤0.01% |
29,700
-16,900
| -36% | -$424K |
|
|
PMC
842
DELISTED
PharMerica Corporation
PMC
| $899K | ﹤0.01% |
31,900
-8,200
| -20% | -$204K |
|
843
Comfort Systems
FIX
$61B
| $898K | ﹤0.01% |
42,700
-6,300
| -13% | -$112K |
|
|
IFN
844
Aberdeen India Fund
IFN
$488M
| $895K | ﹤0.01% |
31,662
| – | – |
|
845
Piper Sandler
PIPR
$5.14B
| $891K | ﹤0.01% |
68,000
+3,200
| +5% | +$43.5K |
|
846
WEX
WEX
$6.11B
| $891K | ﹤0.01% |
8,300
-11,200
| -57% | -$1.13M |
|
847
Tennant Co
TNC
$1.5B
| $889K | ﹤0.01% |
13,600
-300
| -2% | -$20K |
|
|
VG
848
DELISTED
Vonage Holdings Corporation
VG
| $888K | ﹤0.01% |
181,000
-50,900
| -22% | -$227K |
|
|
NXGN
849
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $886K | ﹤0.01% |
55,500
-1,400
| -2% | -$23.2K |
|
|
DF
850
DELISTED
Dean Foods Company
DF
| $886K | ﹤0.01% |
+53,600
| New | +$920K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q1 2015 Portfolio in Review
As of Q1 2015, STRS Ohio held 1,954 positions worth $22.7B, down 1.7% from $23.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
STRS Ohio withdrew a net $683M in Q1 2015, closing 152 positions and reducing 978 holdings. Its most notable exit was Allergan Inc, an estimated $96.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, STRS Ohio opened a new position in Lazard worth $30.5M.
- STRS Ohio's largest Q1 2015 buy was Lazard: 580,430 shares worth $30.5M.
- STRS Ohio added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- STRS Ohio's biggest Q1 2015 reduction was HCA Healthcare, cutting an estimated $70.3M.
- STRS Ohio fully exited Allergan Inc in Q1 2015, selling an estimated $96.8M.
- STRS Ohio's ten largest holdings make up 14% of its $22.7B portfolio in Q1 2015.
- STRS Ohio opened 218 new positions and closed 152 in Q1 2015.
- STRS Ohio's portfolio value fell 1.7% quarter-over-quarter to $22.7B.
Based on STRS Ohio's 13F filing for Q1 2015, filed 21 Apr 2015.